Cargando…

Perivascular Mesenchymal Cells Control Adipose Tissue Macrophage Accrual in Obesity

Chronic low-grade white adipose tissue (WAT) inflammation is a hallmark of metabolic syndrome in obesity. Here, we demonstrate that a subpopulation of murine WAT perivascular (PDGFRβ+) cells, termed “fibro-inflammatory progenitors” (FIPs), activate pro-inflammatory signaling cascades shortly after t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shan, Bo, Shao, Mengle, Zhang, Qianbin, Hepler, Chelsea, Paschoal, Vivian A., Barnes, Spencer D., Vishvanath, Lavanya, An, Yu A., Jia, Lin, Malladi, Venkat S., Strand, Douglas W., Gupta, Olga T., Elmquist, Joel K., Oh, Dayoung, Gupta, Rana K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669663/
https://www.ncbi.nlm.nih.gov/pubmed/33139957
http://dx.doi.org/10.1038/s42255-020-00301-7
Descripción
Sumario:Chronic low-grade white adipose tissue (WAT) inflammation is a hallmark of metabolic syndrome in obesity. Here, we demonstrate that a subpopulation of murine WAT perivascular (PDGFRβ+) cells, termed “fibro-inflammatory progenitors” (FIPs), activate pro-inflammatory signaling cascades shortly after the onset of high-fat diet feeding and regulate pro-inflammatory macrophage accumulation in WAT in a TLR4-dependent manner. FIPs activation in obesity is mediated by the downregulation of ZFP423, identified here as a transcriptional co-repressor of NFκB. ZFP423 suppresses the DNA-binding capacity of the p65 subunit of NFκB by inducing a p300 to NuRD co-regulator switch. Doxycycline-inducible expression of Zfp423 in PDGFRβ+ cells suppresses inflammatory signaling in FIPs and attenuates metabolic inflammation of visceral WAT in obesity. Inducible inactivation of Zfp423 in PDGFRβ+ cells increases FIP activity, exacerbates adipose macrophage accrual, and promotes WAT dysfunction. These studies implicate perivascular mesenchymal cells as important regulators of chronic adipose tissue inflammation in obesity and identify ZFP423 as a transcriptional break on NFκB signaling.